Cargando…
HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination
Integrase inhibitors are a class of antiretroviral drugs used for the treatment of AIDS that target HIV integrase, an enzyme responsible for integration of viral cDNA into host genome. RAG1, a critical enzyme involved in V(D)J recombination exhibits structural similarity to HIV integrase. We find th...
Autores principales: | Nishana, Mayilaadumveettil, Nilavar, Namrata M, Kumari, Rupa, Pandey, Monica, Raghavan, Sathees C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520896/ https://www.ncbi.nlm.nih.gov/pubmed/28569776 http://dx.doi.org/10.1038/cddis.2017.237 |
Ejemplares similares
-
Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor
por: Nilavar, Namrata M., et al.
Publicado: (2020) -
Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers
por: Paranjape, Amita M., et al.
Publicado: (2022) -
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009) -
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009) -
HIV-1 integrase inhibitors targeting various DDE transposases: Retroviral integration versus RAG-mediated recombination
por: Mușat, Mihaela Georgiana, et al.
Publicado: (2019)